Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : COB Columbia Laboratories -- Ignore unavailable to you. Want to Upgrade?

To: John Kessinger who wrote (590)	9/15/1999 11:40:00 PM
From: sally bananas	Read Replies (1) \| Respond to of 634

If COB or Aeres-Serona would mail me some promotional material (whenever it is ready), I would be happy to put it into the hands of all of the local OBGYNs. Seriously, I might request some brochures next year. One interesting aspect of the stories of the increase in multiple births in the US recently: Doctors who suggest the use of Crinone 8% earlier in infertility treatment may help women sustain pregnancy prior to the administration of more complicated procedures or drugs which result in multiple births. In fact, when local OBGYNs learn about Crinone, some (perhaps many) couples will not need to go to Reproductive Endocrinologists. But not to worry, infertility is a growth sector so the infertility specialists won't starve---several years ago I read that they had the highest incomes of any medical practitioners in the US.